NuVasive NUVA

$ 39.75 0.0%

Quarterly report 2023-Q2
added 08-02-2023

NuVasive Balance Sheet 2011-2024 | NUVA

Annual Balance Sheet NuVasive

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-238 M	-235 M	-82.8 M	489 M	485 M	510 M	472 M	350 M	439 M	387 M	283 M	377 M
Long Term Debt	872 K	885 K	766 M	623 M	603 M	583 M	564 M	377 M	361 M	346 M	332 M	394 M
Long Term Debt Current	10 M	9.87 M	7.88 M	5.57 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	763 M	694 M	679 M	628 M	488 M	480 M	458 M	462 M	411 M
Total Current Liabilities	716 M	201 M	836 M	207 M	179 M	161 M	242 M	99.6 M	215 M	117 M	164 M	207 M
Total Liabilities	-	-	-	970 M	873 M	840 M	870 M	587 M	695 M	575 M	626 M	619 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	86.1 M	45.7 M	45.3 M	82.5 M	17.2 M	4.5 M	-66.9 M	-121 M	-187 M	-170 M	-178 M	-181 M
Total Assets	2.22 B	2.15 B	2.69 B	1.89 B	1.71 B	1.64 B	1.57 B	1.29 B	1.34 B	1.18 B	1.16 B	1.12 B
Cash and Cash Equivalents	249 M	246 M	857 M	213 M	118 M	72.8 M	154 M	192 M	142 M	103 M	123 M	163 M
Book Value	2.22 B	2.15 B	2.69 B	915 M	835 M	799 M	701 M	702 M	648 M	605 M	538 M	505 M
Total Shareholders Equity	869 M	795 M	919 M	915 M	835 M	795 M	695 M	695 M	640 M	596 M	538 M	494 M

All numbers in USD currency

Quarterly Balance Sheet NuVasive

	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	890 K	968 K	872 K	822 K	-	800 K	885 K	987 K	1.12 M	1.47 M	1.81 M	1.81 M	1.81 M	1.81 M	905 K	905 K	905 K	905 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	92.5 M	85.1 M	86.1 M	62 M	-	64.9 M	45.7 M	82.4 M	104 M	102 M	45.3 M	45.3 M	45.3 M	45.3 M	82.5 M	82.5 M	82.5 M	82.5 M	17.2 M	17.2 M	17.2 M	17.2 M	4.76 M	4.76 M	4.76 M	4.76 M	-66.9 M	-66.9 M	-66.9 M	-66.9 M	-104 M	-104 M	-104 M	-121 M	-187 M	-187 M	-187 M	-187 M	-170 M	-170 M	-170 M	-170 M	-178 M	-178 M	-178 M	-178 M	-181 M	-181 M	-181 M	-181 M
Total Assets	2.09 B	2.17 B	2.22 B	2.17 B	-	2.16 B	2.15 B	2.13 B	2.15 B	2.16 B	2.69 B	2.69 B	2.69 B	2.69 B	1.89 B	1.89 B	1.89 B	1.89 B	1.71 B	1.71 B	1.71 B	1.71 B	1.64 B	1.64 B	1.64 B	1.64 B	1.57 B	1.57 B	1.57 B	1.57 B	1.3 B	1.3 B	1.3 B	1.29 B	1.34 B	1.34 B	1.34 B	1.34 B	1.18 B	1.18 B	1.18 B	1.18 B	1.16 B	1.16 B	1.16 B	1.16 B	1.12 B	1.12 B	1.12 B	1.12 B
Cash and Cash Equivalents	80.7 M	181 M	249 M	238 M	226 M	205 M	246 M	235 M	204 M	234 M	857 M	857 M	857 M	857 M	213 M	213 M	213 M	213 M	118 M	118 M	118 M	118 M	72.8 M	72.8 M	72.8 M	72.8 M	154 M	154 M	154 M	154 M	192 M	192 M	192 M	192 M	142 M	142 M	142 M	142 M	103 M	103 M	103 M	103 M	123 M	123 M	123 M	123 M	163 M	163 M	163 M	163 M
Book Value	2.09 B	2.17 B	2.22 B	2.17 B	-	2.16 B	2.15 B	2.13 B	2.15 B	2.16 B	2.69 B	2.69 B	2.69 B	2.69 B	1.89 B	1.89 B	1.89 B	1.89 B	1.71 B	1.71 B	1.71 B	1.71 B	1.64 B	1.64 B	1.64 B	1.64 B	1.57 B	1.57 B	1.57 B	1.57 B	1.3 B	1.3 B	1.3 B	1.29 B	1.34 B	1.34 B	1.34 B	1.34 B	1.18 B	1.18 B	1.18 B	1.18 B	1.16 B	1.16 B	1.16 B	1.16 B	1.12 B	1.12 B	1.12 B	1.12 B
Total Shareholders Equity	893 M	874 M	869 M	832 M	827 M	812 M	795 M	824 M	841 M	835 M	919 M	919 M	919 M	919 M	915 M	915 M	915 M	915 M	835 M	804 M	781 M	762 M	796 M	796 M	796 M	796 M	695 M	695 M	695 M	695 M	712 M	712 M	712 M	695 M	640 M	640 M	640 M	640 M	596 M	596 M	596 M	596 M	538 M	538 M	538 M	538 M	494 M	494 M	494 M	494 M

All numbers in USD currency